Clinically, the expression of Linc01056 was correlated with optimal overall and progression-free survival outcomes in HCC patients and was associated with the sorafenib response, as determined by experiments using phospho-Erk as a predictive marker. This evidence concerns the gene LINC01056 and hepatocellular carcinoma.